Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy (TelOG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02583035|
Recruitment Status : Completed
First Posted : October 21, 2015
Last Update Posted : January 16, 2019
There are no recommendations and few studies on the monitoring of fragile patients in the oncological treatment, both on the organizational arrangements on its interest in the prevention of functional deterioration of the patient and adaptation of the potential cancer treatment.
The oncogériatrique evaluation being time-consuming, requiring the movement of these more or less frail elderly patients, it seems difficult to envisage repeated and systematic standardized geriatric assessments during cancer treatment. Geriatric fragility can be detected by telephone. Craven et al. has already assessed the telephone follow-up by a nurse in patients treated for cancer, but with the aim to detect toxicities of cancer treatment, patients are not very old (mean age 64.8 years).
External evaluation by the nurse coordinator of UCOG (Coordination Unit in geriatric oncology) not knowing the patients included avoids bias of subjectivity in the interrogation.
However the telephone monitoring, with the aim to evaluate the evolution of geriatric frailty, has not been specifically studied in the elderly population treated for cancer, while taking oncology load.
The investigators wish to study the feasibility and validity of telephone follow-up which could eventually be used routinely to identify patients requiring further medical consultation oncogériatrique.
|Condition or disease||Intervention/treatment||Phase|
|Cancer Hematologic Malignancy||Other: Nurse telephone contact||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||131 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy|
|Study Start Date :||February 2015|
|Actual Primary Completion Date :||February 16, 2018|
|Actual Study Completion Date :||May 14, 2018|
Nurse telephone contact
3 days of consultation, telephone follow-up of the patient by the nurse coordinator of the Geriatric Oncology Unit to validate
Other: Nurse telephone contact
Nurse will contact patient 3 days before consultation
- Memory on the Mini Mental Scale [ Time Frame: 3 months after inclusion ]
- Falls on the number of falls [ Time Frame: 3 months after inclusion ]
- Pain on the EVS (verbal scale) scale [ Time Frame: 3 months after inclusion ]
- Autonomy on the ADL (activities of daily living) score [ Time Frame: 3 months after inclusion ]
- Pain on the EN (numericale scale) scale [ Time Frame: 3 months after inclusion ]
- Autonomy on the IADL (The Lawton Instrumental Activities of Daily Living Scale ) score [ Time Frame: 3 months after inclusion ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02583035
|Caen, France, 14033|
|Centre François Baclesse|
|Caen, France, 14400|
|Centre Hospitalier du Havre|
|Le Havre, France|
|Principal Investigator:||Bérengère Beauplet, MD||University Hospital, Caen|